# OnCo record paper-hietanen-rigvir-echovirus-viruses-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-hietanen-rigvir-echovirus-viruses-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-hietanen-rigvir-echovirus-viruses-2022" ;
  schema:name "Hietanen 2022: the marketed oncolytic virus Rigvir was no more oncolytic than any other echovirus isolate"@en ;
  schema:description "A virus sold for years as a cancer treatment in Latvia was sequenced and tested against ordinary strains of the same virus, and it killed cancer cells no better, and infected healthy cells too."@en ;
  schema:url <https://onco.cc/key-papers/paper-hietanen-rigvir-echovirus-viruses-2022/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.3390/v14030525>, <https://pubmed.ncbi.nlm.nih.gov/35336934/>, <https://doi.org/10.3390/v14092078> ;
  schema:sameAs <https://doi.org/10.3390/v14030525> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Hietanen E, Koivu MKA, Susi P" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/oncolytic-virus/> .